Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ · Real-Time Price · USD
8.99
+0.12 (1.33%)
At close: Oct 9, 2026, 4:00 PM EDT
9.26
+0.27 (3.02%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Polyrizon Employees
As of December 31, 2025, Polyrizon had 4 total employees, including 2 full-time and 4 part-time employees. The number of employees decreased by 2 or -33.33% compared to the previous year. That makes Polyrizon the 42,350th largest employer in the world and 6,777th in the United States.
Employees
4
Change (1Y)
-2
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$1,145,500
Market Cap
21.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | -2 | -33.33% | 2 | 2 |
| Dec 31, 2024 | 6 | - | - | 2 | 4 |
Related Stocks
| Company Name | Employees |
|---|---|
| aTyr Pharma | 60 |
| BeyondSpring | 44 |
| Kyntra Bio | 34 |
| Jasper Therapeutics | 22 |
| SeaStar Medical Holding | 18 |
| Quantum BioPharma | 17 |
| Atossa Therapeutics | 16 |
| Psyence Biomedical | 12 |
PLRZ News
- 5 days ago - Polyrizon files U.S. patent application for mucoadhesive technology - TheFly
- 5 days ago - Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform - GlobeNewsWire
- 18 days ago - Polyrizon enrolls first patient in U.S. study of NASARIX - TheFly
- 18 days ago - Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker - GlobeNewsWire
- 22 days ago - Polyrizon files to sell 404,166 ordinary shares for holders - TheFly
- 5 weeks ago - Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement - GlobeNewsWire
- 5 weeks ago - Polyrizon announces $4.0M registered direct offering - TheFly
- 5 weeks ago - Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement - GlobeNewsWire